Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma

NCT01447459 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2017-11-17

No results posted yet for this study

Summary

The investigators hypothesize that reinforced asthma education improves long-term outcomes in children with asthma.

Specific Aims and Objectives:

1. To determine the retention rate of parental knowledge about asthma;
2. To evaluate the clinical status, quality of life and healthcare costs of children with asthma following an educational intervention.

Conditions

Interventions

BEHAVIORAL

Reinforced Asthma Education

Before beginning the actual study, a board-certified Asthma Educator (AE) will prepare and administer an asthma education training session for the study personnel, including the PI, the co-investigators, and the study coordinator. The AE will also make herself available via pager for assistance with questions from the study personnel regarding asthma education. At the end of the administration of the phone surveys (i.e. at 2 weeks, 1 month and 3 months following enrollment), the study coordinator will provide reinforced asthma education to the caregiver via telephone for the subjects enrolled in Group A (the intervention group). The reinforced asthma education will be consistent with the asthma education training session delivered by the AE before the beginning of the study.

Sponsors & Collaborators

  • Passport Health

    collaborator INDUSTRY
  • University of Louisville

    lead OTHER

Principal Investigators

  • Carmen T Condurache, M.D. · University of Louisville

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01447459 on ClinicalTrials.gov